… phages specifically binding to lung cancer tumors. Principles of … dual-targeted phage increased gefitinib concentration in brain … applied to target lung cancer cells, especially brain … in lung cancer patients or using transplanted lung cancer animal …

… personalized nanotherapeutics for lung cancer treatment. Emerging Strategies … photosensitizer delivery for lung cancer treatment are … in immunotherapy–resistant lung tumor. Int Immunopharmacol. … signaling to overcome gefitinib resistance. Nano Lett …

… in non-small cell lung cancer patients treated with … cell lung cancer from an Italian knowledge-based database. Lung Cancer. … paclitaxel on gefitinib-resistant non-small cell lung cancer cells. … in non-small cell lung cancer: reproducibility and implications …

… advanced non–small-cell lung cancer (NSCLC).  The recommendation … survival compared with standard gefitinib monotherapy in patients with … with 35.8% receiving gefitinib. Notably, skin rash, … frequently with aumolertinib than gefitinib. Aumseqa will be …

… patients with EGFR-mutated lung cancers, according to Girindra Raval … of the EGFR-mutated lung cancer landscape, emphasizing the … like] erlotinib [Tarceva] and gefitinib [Iressa] to the more … patients with EGFR-mutated lung cancer or other cancer populations? …

… for patients with EGFR-mutated lung cancers as well as emerging therapies … EGFR inhibitors, including erlotinib (Tarceva), gefitinib (Iressa), and osimertinib (Tagrisso), the … for treatment of EGFR-mutated lung cancer in the metastatic setting. Now …

… osimertinib resistance in lung cancer by inhibiting the CD44 … positive non-small-cell lung cancer (FURLONG): a multicentre … regulate tumorigenicity and gefitinib resistance in lung cancer. Cell Death … non-small cell lung cancer. Transl Lung Cancer Res. 2022;11 …

… of non-small-cell lung cancer to gefitinib. N Engl J … mutant non-small cell lung cancer. Lung Cancer. 2014;86(2): … EGFR mutated lung cancers: correlation with clinical outcomes. Lung Cancer. 2017; … advanced non-small-cell lung cancer. Lung Cancer. 2022;166:9–16 …

… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … of lung cancer. Current treatment modalities for lung cancer include … -CPT-NPs inhibited lung tumor growth by promoting … non-small cell lung cancer with gefitinib. J Fluoresc. …

… lung cancer (NSCLC)—which accounts for 80-85% of all lung cancer … recurrence and metastasis of lung cancer, eliminating them could … inhibitors like erlotinib and gefitinib initially provide clinical benefit … were effective even in lung cancer cells that had …